What did @saintaestheticsclinic actually say?
Here's the awkward part: the transcript contains no medical claims at all. The words spoken are "I've been praying all this season, Beauty my fate all been strength, Moving from grace to grace, From high to high, Spreading his words." That appears to be song lyrics or a prayer, not a clinical explanation of anything.
The actual claims live entirely in the caption, which promises that these injections "boost fat breakdown," "support weight loss," and help "target stubborn areas" for body contouring. The caption never names a specific ingredient, drug, or mechanism. That vagueness is doing a lot of work here. It could be referring to GLP-1 receptor agonists like semaglutide, lipotropic injections, phosphatidylcholine, or something else entirely. The viewer has no way to know, and that ambiguity is a problem on a platform reaching nearly half a million people.
Does the science back this up?
It depends entirely on what they're actually injecting, which they never say. GLP-1 receptor agonists have legitimate clinical backing. Everything else in this space ranges from "mildly supported" to "not really proven."
If the product is semaglutide or tirzepatide, the evidence is genuinely strong. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) found tirzepatide produced up to 22.5% body weight reduction in adults with obesity. The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide 2.4mg produced roughly 14.9% weight loss versus 2.4% with placebo. These are real numbers from large, rigorous trials.
If the product is lipotropic injections, B12 shots, or phosphatidylcholine, the evidence is far weaker. A 2011 review by Duncan et al. in the Journal of Drugs in Dermatology found phosphatidylcholine injections showed some localized fat reduction, but the evidence base was small and the safety profile was inconsistent. Calling any of these "fat burning" injections in a blanket way overstates what the science actually supports.
What did they get wrong (or right)?
They got the broad GLP-1 category right in spirit, if that's what they're selling. These drugs do produce meaningful weight loss and do help with body composition when used as part of a managed program. Credit where it's due.
But the caption is misleading in three specific ways. First, the phrase "boost fat breakdown" implies a targeted, local fat-burning effect that no systemic injection actually delivers. GLP-1 agonists work through appetite suppression and slowed gastric emptying (Drucker, 2018, Cell Metabolism), not by dissolving fat in specific spots. Second, "targeting stubborn areas" is classic body contouring marketing language that has no grounding in how GLP-1 drugs work. You cannot direct where a systemic drug burns fat. Third, no specific drug, dose, or regulatory status is mentioned anywhere, which means a viewer could walk away thinking any "slimming injection" from any provider is safe and equivalent. That's not how this works.
- Claiming localized fat targeting from a systemic injection: misleading
- Omitting the drug name and regulatory context entirely: a significant gap
- The general weight loss claim for GLP-1 class drugs: supported by evidence
What should you actually know?
If you're considering any injectable for weight loss, the single most important question is: what is the actual drug, and who is prescribing it? This video answers neither question.
GLP-1 receptor agonists are prescription medications with real side effect profiles. Nausea, vomiting, and gastrointestinal symptoms are common, particularly early in treatment. The FDA has also flagged concerns about compounded versions of semaglutide, noting that compounded drugs are not FDA-approved and are not equivalent to brand-name products like Wegovy or Ozempic. Anyone offering "slimming injections" without naming the active ingredient and providing a prescribing pathway should prompt serious questions from any potential patient.
Body contouring language also tends to set unrealistic expectations. Even in the STEP trials, results varied significantly across individuals. Weight loss drugs work best as part of a broader clinical program that includes dietary support and monitoring, not as a standalone aesthetic service marketed through hashtags.
Before booking anything, ask for the prescriber's name, the drug name and dose, and whether the provider is operating under a legitimate telehealth or in-person clinical framework. Vague captions and aesthetic clinic branding are not substitutes for that information.